FDAnews
www.fdanews.com/articles/84933-aeterna-zentaris-swings-to-q4-profit-of-us-936k-from-year-ago-2m-loss

AETERNA ZENTARIS SWINGS TO Q4 PROFIT OF US$936K FROM YEAR-AGO $2M LOSS

March 1, 2006

Cancer drug developer AEterna Zentaris Inc. swung to a fourth quarter profit as a big jump in revenues helped reverse a loss last year. The Quebec-based company said Wednesday it earned US$936,000 or two cents a share for the three months ended Dec. 31. That compared with a net loss of US$2 million or four cents a share for the same 2004 period.

Canada.com (http://bodyandhealth.canada.com/channel_health_news_details.asp?news_id=9401&news_channel_id=12&channel_id=12&rot=11)